The Clinical Trials Network for the Prevention and Early Treatment of Acute Lung Injury (PETAL) is a network of 12 Clinical Centers (CC) and one Clinical Coordinating Center (CCC) funded by the National Heart, Lung, and Blood Institute (NHLBI) to develop and conduct randomized controlled clinical trials to prevent or treat Acute Respiratory Distress Syndrome (ARDS). The Network will test new treatments or approaches with the potential to improve important clinical outcomes of patients with ARDS and for patients at risk for developing ARDS. This project will build on the strengths and accomplishments of the NHLBI funded Acute Respiratory Distress Syndrome Clinical Trial Network (ARDSNet) and emergency/acute care medicine research groups to focus on prevention and earlier intervention. PETAL will forge new partnerships and approaches by using a teamwork approach; allowing clinicians from many areas to work together in the course of the project. This grant is to set up administrative staffing to execute clinical trials under this network
|Effective start/end date||8/1/17 → 4/30/21|
- Cleveland Clinic Lerner College of Medicine of CWRU (938-SUB // U01HL123023)
- National Heart, Lung, and Blood Institute (938-SUB // U01HL123023)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.